CELL AND GENE THERAPY INSIGHTS

Optimizing iPSC-derived cell therapy development

Optimizing iPSC-derived cell therapy development

Omar Farah
09 July 2025
Register
To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Leisha Kopp, Mason Bonitz
03 June 2025
Watch
Cryopreservation of autologous patient material for onwards manufacture

Cryopreservation of autologous patient material for onwards manufacture

Chris Leonforte
02 June 2025
Viewpoint
Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Tia Harmon
07 May 2025
FastFacts
Digitalization and data analytics: shaping the future of cell bioprocessing

Digitalization and data analytics: shaping the future of cell bioprocessing

Mohamed Noor
01 May 2025
Interview
Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz
02 April 2025
Watch
Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng
20 March 2025
Innovator Insight
Streamlining the supply chain: insights on raw material sourcing and quality by design

Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman
19 March 2025
Interview
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel
18 March 2025
Watch
Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald
11 March 2025
Commentary
Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Mark Kennedy, Marcus Bunn
10 March 2025
Innovator Insight
Raw and starting materials for cellular and gene therapy products

Raw and starting materials for cellular and gene therapy products

Gary du Moulin
04 March 2025
Review
Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Phil Morton, Shanya Jiang
03 March 2025
Innovator Insight
Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al
27 February 2025
Innovator Insight
Investing in early-stage stem cell therapy developers

Investing in early-stage stem cell therapy developers

Stijn Heessen, Kristian Tryggvason
21 February 2025
Viewpoint
Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Michael DiBiasio-White, Ying Cai, Roland Pach
06 February 2025
Watch
Driving innovation in cell and gene therapy: the role of AI and robotics

Driving innovation in cell and gene therapy: the role of AI and robotics

Kenneth Harris, Mitchel Sivilotti, Anthony Rotunno
27 January 2025
Interview
What removing the DNA synthesis bottleneck means for the future of drug discovery and development

What removing the DNA synthesis bottleneck means for the future of drug discovery and development

Elizabeth Wood
14 January 2025
Interview
Connecting innovations to great gains for the ultimate stakeholder: the patient

Connecting innovations to great gains for the ultimate stakeholder: the patient

Michelle Berg
13 January 2025
Foreword
Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland

Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland

Athanasios Mantalaris, Nicki Panoskaltsis, Fiona Killard
13 January 2025
Commentary
Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

R Luke, M Giedlin, D Clarke et al
12 December 2024
Watch